Skip to content

INFLAMMATORY INJURY of the LUNG after CARDIAC SURGERY

INFLAMMATORY INJURY of the LUNG after CARDIAC SURGERY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24292
Enrollment
160
Registered
2015-05-26
Start date
2011-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Lung injury, Cardiac Surgery, CPB, Ivflammatory response

Interventions

none

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients, that are scheduled for all types of elective cardiac surgery, with or without CPB. For the purpose of the study low risk cardiac surgery is defined as CABG with single valve reconstruction or replacement. Complex cardiac surgery is defined as: multiple valves reconstruction or replacement, and/or heart failure surgery (DOR, corcap)

Exclusion criteria

Exclusion criteria: Inability to sign informed consent, less than 18 years old, emergency operations

Design outcomes

Primary

MeasureTime frame
Length of ICU-stay, length of hospital-stay, ICU-mortality, 30-day mortality

Secondary

MeasureTime frame
1. Prognostic: occurrence of ALI and ARDS, duration of mechanical ventilation, need for renal replacement therapy 2. Etiologic: levels and time course of markers of inflammation and ischemia-reperfusion in relation to the clinical course (such as AlI and ARDS, duration of mechanical ventilation, need for renal replacement therapy, ICU-stay, hospital-stay, ICU-mortality, 30-day mortality) particular in patients following complex heart surgery as opposed to low risk surgery 3. Methodologic: Investigate the value of collecting minimal invasive endobronchial samples in cardiac surgery patients.

Contacts

Public ContactJudith van Paassen

Department of Intensive Care - Location J4-24, LUMC

Email: j.van_paassen@lumc.nlTelephone: 071-5262782

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)